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tomy technique in which a ring stripper was used that
achieved patency rates similar to those of AKFP bypass
graft. Although this procedure required two incisions, it
avoided the use of prosthetic grafts or harvesting of the
saphenous vein, which could be used for subsequent car-
diovascular or peripheral reconstructions. With the devel-
opment of the remote endarterectomy technique reported
by Ho et al,10 a minimally invasive operation performed
through a single incision in combination with endovascu-
lar stent or stent-graft placement was devised.
The purpose of this study was to examine the
medium-term results of remote superficial femoral artery
endarterectomy (RSFAE) in a retrospective multicenter
study.
METHODS
Between March 1996 and October 2000, 60 patients
underwent RSFAE as part of a retrospective multicenter
study. The study centers and their respective number of
RSFAEs were Atlanta Medical Center, Atlanta, Ga (16);
O’Connor Hospital, San Jose, Calif (27); Baptist East
Hospital, Louisville, Ky (8); and Anne Arundel Medical
Center, Annapolis, Md (9). The indications for operation
were claudication in 52 patients and limb salvage in eight
patients. Forty-six patients were men, and the mean
patient age was 66.2 years (range, 49-81 years). Twenty-
eight patients (46.7%) had a history of cigarette smoking,
29 (48.3%) had hypertension, 26 (43.3%) had diabetes
mellitus, and 21 (35.0%) had coronary artery disease.
In 1947, the Portuguese surgeon Cid Dos Santos1
performed the first successful “disobstruction” of an ath-
erosclerotic superficial femoral artery (SFA) by removing
the diseased inner layer of the artery wall. Dos Santos
termed this procedure thromboendarterectomy. Since this
initial report, the popularity of SFA endarterectomy has
waxed and waned, but the technique was gradually aban-
doned in the United States because published reports2,3
indicated that above-knee femoropopliteal (AKFP) bypass
graft offered patency rates that were superior to those of
SFA endarterectomy.
The advent, however, of minimally invasive proce-
dures, such as percutaneous transluminal angioplasty
(PTA), laser-assisted balloon angioplasty, and atherec-
tomy, the results of which have been disappointing in
treatment of long-segment (>10 cm) SFA occlusive dis-
ease, stimulated a reassessment of SFA endarterectomy.4-7
Two 1993 reports8,9 advocated a semiclosed endarterec-
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Objective: The results of percutaneous transluminal angioplasty, atherectomy, and laser angioplasty for the treatment of
long-segment (>10 cm) superficial femoral artery (SFA) occlusive disease have proved disappointing. Remote superfi-
cial femoral artery endarterectomy (RSFAE) is a minimally invasive procedure, performed through a single limited
groin incision that may offer patency rates comparable with those of above-knee femoropopliteal (AKFP) bypass graft.
In this retrospective multicenter study the medium-term results of RSFAE are examined.
Methods: Sixty patients were included in this study. Indications for the procedure were claudication in 52 patients and
limb salvage in eight patients. RSFAE was performed with the MollRing Cutter device through a femoral arteriotomy.
The distal “flap” of atheroma was anchored by balloon/stent angioplasty through the femoral arteriotomy. All patients
underwent a follow-up examination with serial color flow ultrasound scanning.
Results: Ten patients with heavily calcified SFAs failed as “intentions to treat”; these patients underwent AKFP bypass
grafting. The mean length of the endarterectomized SFAs was 22.3 cm (range, 8-37 cm). The primary cumulative
patency rate by means of life-table analysis was 61.4% ± 9% (SE), (mean, 12.9 months; range, 3-36 months). During
follow-up, percutaneous transluminal angioplasty was necessary in 14 patients, for a primary-assisted patency rate of
82.6% ± 8%. The locations of the restenoses after RSFAE were evenly distributed along the endarterectomized SFAs.
There were no deaths and one wound complication (hematoma), and the mean hospital length of stay was 1.4 days ±
0.8 days.
Conclusions: RSFAE is a safe and moderately durable procedure. If long-term patency rates are similar to those of AKFP
bypass graft, RSFAE may prove to be a minimally invasive adjunct for the treatment of SFA occlusive disease that will
lower operative morbidity, reduce hospital LOS, and shorten recuperation. (J Vasc Surg 2001;34:428-33.)
The technique for RSFAE has been previously
described by Ho et al10 and is illustrated in Fig 1. In sum-
mary, the common, proximal profunda femoral, and prox-
imal SFAs are exposed through a small groin incision.
After systemic heparin administration, a 3-cm arteriotomy
is made from the origin of the SFA distally, and an
endarterectomy is started between the inner and outer
media. This intimal core is transversely cut at the SFA ori-
gin and threaded into the loop of a conventional (Vollmar)
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ring stripper. The ring stripper is advanced distally down
the SFA beyond the occluded segment, the location of
which has been determined with intraoperative arteriogra-
phy and “road mapping.” The ring stripper is exchanged
for the MollRing Cutter device (Vascular Architects, San
Jose, Calif), which transects the distal atheroma core
under fluoroscopic surveillance. The entire core is
removed, and arteriography is performed to confirm a
patent distal artery.
Fig 1. Diagram to illustrate current technique of remote endarterectomy. A, Endarterectomy has been performed with ring stripper
(not shown) just distal to end of occlusion. B, MollRing Cutter passed to same position in endarterectomy plane (inset shows ring cut-
ter closed). C, Ring cutter transects atheroma at chosen level (inset shows relative movement of rings). D, Atheromatous core removed
proximally leaving free edge of cut atheroma. E, Diagrammatic representation of Palmez stent in position. (Reprinted with permission
from Whiteley MS, Magee TR, Tarrie EP, Galland RB. Minimally invasive superficial femoral artery endarterectomy: Early experience
with a modified technique. Eur J Vasc Endovasc Surg 1998;16:254-8.)
Fig 2. A, Arteriogram after RSFAE. Note distal “shelf” at endarterectomy end point. B, Balloon/stent angioplasty. C, Completion arte-
riogram.
 Image available in print only
Under fluoroscopic guidance, a guidewire is passed
across the distal SFA endarterectomy end point, and bal-
loon/stent angioplasty is performed,”tacking” the distal
plaque to prevent further dissection (Fig 2). Completion
arteriography verifies RSFAE patency and any outflow tract
obstruction. Loose debris, visualized with arteriography, is
removed with a Fogarty embolectomy or graft thrombec-
tomy catheter (Edwards Lifesciences, Vascular Division,
Irvine, Calif). The arteriotomy may be extended proxi-
mally to perform an open endarterectomy of the common
femoral artery or profunda femoris ostia, as necessary.
Technical success was defined as any recanalization of
an occlusive lesion on completion arteriography. All patients
underwent clinical evaluation during the 30-day postopera-
tive period with duplex color flow ultrasound scanning. The
patients were followed up at 3-, 6-, and 12-month intervals
and at 6-month intervals thereafter with color flow duplex
ultrasound scanning. RSFAE patency was confirmed with
duplex scan or arteriographic evaluation. The primary end
point was any occlusion or radiologic or surgical interven-
tion before occlusion. Cumulative primary and primary-
assisted patency rates were calculated with the actuarial
life-table method based on the number of procedures per-
formed (Fig 3). Because the study was retrospective in
nature, all statistical analyses must be guarded.
RESULTS
Initial technical success was achieved in 57 (81.4%) of
70 cases. In three patients who underwent successful
RSFAE, the guidewire could not be passed across the
residual popliteal plaque, and the procedure was aban-
doned. In 10 other patients with heavily calcified femoral
arteries, RSFAE could not be performed when the ring
stripper could not be passed distally, and the patients were
excluded from the study. All of the patients in whom
RSFAE could not be performed underwent uneventful
AKFP bypass grafting.
Therefore, the study group consisted of 60 patients
who underwent RSFAE. The mean length of endarterec-
tomized SFAs was 22.3 cm (range, 8-37 cm). In 32
JOURNAL OF VASCULAR SURGERY
430 Rosenthal et al September 2001
patients, a common femoral artery and profunda femoris
ostia endarterectomy was performed, also. Completion
arteriography demonstrated SFA thrombus in five
patients, which was successfully removed with a Fogarty
balloon catheter. In two other patients, arteriography
showed residual fractured plaque, which was removed
with a Fogarty graft thrombectomy catheter. Three
patients had extravasation of contrast at completion arte-
riography, but this was self-limiting and required no inter-
vention. Thirty-nine of the 60 arteriotomies were closed
with patch angioplasty (16 with autogenous vein and 23
with prosthetic patch material).
The primary cumulative patency rate by means of life-
table analysis was 61.4% ± 9% (SE), (mean, 12.9 months;
range, 3-36 months) (Table). Repeat radiologic interven-
tion was necessary in 14 patients (9 PTA, 5 stent angio-
plasty), for a primary-assisted patency rate of 82.6% ± 8%.
The locations of the stenoses after RSFAE included 6 that
were over the course of the SFA and 4 at the adductor
canal in long (>20 cm) endarterectomies, 2 at the SFA ori-
gin, and 2 at the distal stent. One below-knee amputation
was performed during follow-up in a patient who was dia-
betic and dialysis dependent with gangrene of the fore-
foot. He underwent successful RSFAE, but amputation
was necessary despite a patent SFA endarterectomy. There
were no deaths and one wound complication (hematoma),
and the mean hospital length of stay was 1.4 ± 0.8 days.
The ankle/brachial indices rose from 0.61 (± 0.16) pre-
operatively to 0.97 (± 0.05) postoperatively.
DISCUSSION
RSFAE, in combination with popliteal artery
balloon/stent angioplasty, offers the vascular surgeon a min-
imally invasive alternative to radiologic endoluminal proce-
dures for the treatment of infrainguinal occlusive disease.
The disappointing results reported4-7 for long-segment 
(>10 cm) SFA occlusive disease with PTA, laser-assisted bal-
loon angioplasty, and atherectomy led van der Heijden et al9
to reassess semiclosed endarterectomy because “debulking”
of the SFA would hopefully improve patency. They reported
Cumulative primary patency rates for RSFAE procedures
No. of No. of Interval Cumulative
grafts grafts Lost to Total patency patency
Interval at risk failed follow-up withdrawn rate (%) rate (%) SE
0-3 mo 60 4 3 7 93.3 93.2 0
3-6 mo 53 2 6 8 96.2 89.4 3.3
6-9 mo 45 3 8 11 93.3 82.8 5.2
9-12 mo 34 3 6 9 91.2 74.9 5.2
12-15 mo 25 3 6 9 88.0 64.6 6.4
15-18 mo 16 0 2 2 100.0 64.6 7.8
18-21 mo 14 1 3 4 92.6 61.4 7.8
21-24 mo 10 0 0 4 100.0 61.4 8.8
24-27 mo 6 0 0 0 100.0 61.4 8.8
27-30 mo 6 0 2 2 100.0 61.4 8.8
30-33 mo 4 0 1 1 100.0 61.4 8.8
33-36 mo 3 0 1 1 100.0 61.4 8.8
a technical success rate of 89% and a 5-year secondary
patency rate of 61% in 259 SFA endarterectomies, which
compares favorably with the results of conventional bypass
operations. With this technique, a ring stripper was intro-
duced through arteriotomies at the common femoral and
above-knee popliteal arteries, and endarterectomy was per-
formed. The distal popliteal artery plaque was “tacked” with
sutures. The development by Ho et al10 of the remote
endarterectomy technique, performed through a single
short groin incision in combination with distal plaque bal-
loon/stent angioplasty, offered several advantages. It was
minimally invasive, a second distal incision was avoided, and
common femoral and profunda femoris ostial endarterec-
tomy could be easily performed, as necessary. It avoided use
of prosthetic material, it could be used in the absence of
saphenous vein, and, alternatively, it allowed preservation of
the saphenous vein for subsequent reconstructions in the
cardiovascular or peripheral circulation.
The 12-month (74.9%) and 36-month (61.4%) pri-
mary cumulative patency rates in this study were similar to
those reported by Ho et al11 and were comparable with
rates expected after AKFP bypass graft. Part of the “learn-
ing curve” of any new procedure is patient selection. In
this study, patients with heavily calcified SFAs (ie, patients
with renal failure) fared poorly and are likely not candi-
dates for this procedure. The incidence, however, of
stenosis formation after RSFAE was important in that 14
(23.3%) of 60 patients required an adjunctive procedure
(9 PTA, 5 stent angioplasty) to maintain SFA patency.
Although the incidence (23%) of early (<2 years) stenosis
in this study, likely due to intimal hyperplasia, was less than
that reported by Ho et al11 (46% at 1 year) and by Galland
et al12 (69% at 15 months), the reason is unclear, but
remains a major concern. The endarterectomized SFA,
because of its long length, tortuosity, small caliber, and
relatively low flow, may not be able to withstand exuber-
ant intimal hyperplasia formation and arterial recoil.
Interestingly, we observed that when an RSFAE failed, the
patient’s symptoms were, in general, less severe than
before the procedure, which may be due to “opening” of
collaterals at the time of endarterectomy, or the benefit of
an adjunctive profunda femoris endarterectomy in 32
patients. This remains to be proven.
Debulking and SFA endografting, however, may suffi-
ciently obviate the problem of restenosis along the SFA to
offer patency rates comparable with those of AKFP bypass
graft. Nevertheless, information, on SFA endografting is
limited. For example, polytetrafluoroethylene (PTFE)
node size has been reported to be significantly smaller in
dilated, thin-walled expanded PTFE grafts without change
in internodal distance after dilation, and the healing mech-
anisms of high-porosity versus standard PTFE grafts are
not understood.13,14 The controversy surrounding the
incidence of SFA endograft stenosis is interesting, because
some authors15-17 think the stent-graft limits formation of
neointimal hyperplasia, whereas others think that the pres-
ence of an endograft accelerates neointimal hyperplasia
formation.
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The treatment of femoropopliteal occlusive disease
with RSFAE in combination with popliteal stent angio-
plasty or endovascular grafts continues to evolve. Many
questions, however, remain unanswered. What role does a
stent at the endarterectomy end point play? Can a better
stent be designed (ie, tapered or a “step-down”)? Is it nec-
essary to line the debulked atherosclerotic segment with
an endograft? If so, what is the most appropriate graft
material, and should a low profile endograft be structurally
supported? Percutaneous catheter-based radiologic SFA
endografts are currently being developed by major graft
companies for the treatment of SFA occlusive disease. It is
incumbent on the vascular surgeon to develop a minimally
invasive alternative to these radiologic procedures that will
offer patients a procedure of comparable morbidity but
with patency rates similar to those of AKFP bypass graft.
RSFAE is a safe and moderately durable procedure that
may lower operative morbidity, reduce hospital length of
stay, and shorten recuperation.
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DISCUSSION
Dr Stanley O. Snyder (Nashville, Tenn). In Nashville when
we need someone dependable to do a good job, we give the ball
to Eddie George. At the Southern Association of Vascular
Surgery, when we need someone dependable, we give the data
and the podium to president-elect David Rosenthal. Once again
David has chosen an interesting clinical procedure and compiled
an impressive number of cases for review. The concept of superfi-
cial femoral endarterectomy, though certainly not new, has been
resilient for a number of years with numerous advocates and rea-
sonable long-term patency results in patients with short segment
disease. Dr Jim DeWeese, an honorary member of our society,
and his associates reported at our 1985 SAVS meeting in Palm
Springs on 94 patients undergoing various open and semi-closed
localized SFA endarterectomy procedures performed between
1959 and 1984 with a 7-year patency rate of 57%.
The concept presented today of a “remote” SFA endarterec-
tomy for long-segment occlusive disease combined with endovas-
cular techniques is attractive for its potential avoidance of
prosthetic graft material. However, 23 arteriotomies were closed
with prosthetic patches. It is also attractive for the fact that no
bridges have been burned to prevent later, more distal recon-
struction attempts. The primary cumulative patency of 69% at 36
months is impressively high but represents only a few patients
with this follow-up at risk. In reviewing the manuscript (that
impressively arrived several weeks ago), the follow-up tables were
presented on only 60 patients, while 10 others were excluded as
failed intention-to-treat secondary to calcified femoral arteries.
I applaud Dr Rosenthal and his colleagues for this presenta-
tion and for bringing this interesting procedure and data to our
attention.
I do have three questions:
1. A high restenosis rate was noted with 14 of 60 patients
requiring a later adjunctive endovascular procedure. Ho et al
recently reported in the July JVS issue that early elevation of
peak systolic velocities after this procedure often return to
normal with follow-up. What were your noninvasive criteria
for intervention for restenosis?
2. Do you have any thoughts regarding the potential for radia-
tion to help prevent restenosis, and what were your
antiplatelet and anticoagulation regimens in these patients? 
3. In three patients the procedure was unsuccessful because of
the inability to pass a guideline through the area of residual
distal plaque. Did you consider an attempt to pass the
guidewire retrograde from the popliteal approach, and is
there any potential for disobliterating a short segment or
midthigh stenosis or occlusion with these techniques men-
tioned through a posterior popliteal approach, thus saving
the groin for a later bypass procedure?
I would like to thank the society for the opportunity of
reviewing this paper and the privilege of the floor.
Thank you.
Dr David Rosenthal. Thanks, Stan. In the study protocol, the
patients were followed up with postoperative duplex ultrasound
at 3, 6, and 12 months and 6 months thereafter. We followed
peak systolic velocities as you mentioned; some did indeed return
towards baseline with vessel remodeling. More important, I
believe, is the necessity to follow a restenotic lesion that pro-
gresses. If this occurred, we treated these lesions aggressively, and
the patient underwent a percutaneous balloon or stent angio-
plasty procedure.
Your second question related to postoperative antiplatelet or
anticoagulant regimens. The patients in this study were placed on
antiplatelet agents—aspirin, Plavix, or Ticlid at the surgeon’s dis-
cretion—but not anticoagulants. Your question about radiation is
intriguing. As you are aware, the interventional cardiologists are
treating restenosed coronary arteries after angioplasty with a vari-
ety of beta and gamma radiation sources labeled onto a variety of
catheters, balloons, and stents in the hope of inhibiting intimal
hyperplasia. I have been involved with research in this area, label-
ing beta radiation emitting isotopes onto various backbone struc-
tures such as polypropylene, and I can tell you beta radiation
inhibits intimal hyperplasia. This may prove to be a useful adjunct
in remote endarterectomy and is something to look into.
Your last question, Stan, had to do with the popliteal
approach to cross difficult plaque end points and the benefit of
leaving the inguinal region virgin. If you are speaking about a per-
cutaneous popliteal approach in order to pass a guide wire across
distal plaque, this is not unreasonable. Dr Galland’s group in
England reported just such a technique in the European Journal
of Vascular and Endovascular Surgery in 1996. They recom-
mended this technique when they could not pass a guidewire
after a remote endarterectomy from the femoral approach. They
passed a guidewire under ultrasound surveillance through the
popliteal approach in order to stent or balloon distal plaque.
I don’t think I would do a remote endarterectomy through
a posterior popliteal incision, as it is more morbid than a simple
cutdown over the femoral artery. Technically though you could
do this procedure through a posterior popliteal approach for a
midthigh lesion. Interesting idea.
Dr John A. Mannick (Boston, Mass). David, I enjoyed the
paper. I have felt for a long time that there is a role for femoral
endarterectomy, particularly in individuals who do not have suffi-
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cient length of usable vein for a bypass graft, and I have had a
modest personal experience with closed endarterectomy using the
vibrating loop that the Zimmer Company produced some years
back. We found, as you did, that there was a very high incidence
of restenosis in the endarterectomized segment, but it always
occurred early, and, as a surprise to us anyway, it responded very
well to balloon angioplasty, which produced a very durable long-
term result. Have you seen any late failures at the 2- and 3-year
level when you have gone through your angioplasty procedure?
Are these people as we have found relatively immune for stenosis
for a long period of time, very much like an autogenous bypass?
Again, I enjoyed the paper very much.
Dr Rosenthal. Thanks, John. Inherent in what you are saying
is that when we have to intervene early (eg, within 2 years) we are
describing an intimal hyperplastic lesion. These restenoses are
more amenable to balloon or stent angioplasty than atherosclero-
sis and yield a more durable result. We did have late failures, but
I cannot honestly tell you what caused the endarterectomies to
fail. My guess is that the late failures occurred at the outflow tract,
but I don’t have sufficient data to prove this.
Dr Mark Jackson (Dallas, Tex). What was the status of the
limbs in the patients who occluded their SFA? Did you have any
patients who developed any limb-threatening ischemia with either
grade 2 or grade 3 ischemia?
Dr Rosenthal. As you saw from the indications for the proce-
dure slide, I believe 52 of these patients were claudicants. An
anecdotal finding of interest was that after a remote endarterec-
tomy, at arteriography, we frequently see an exuberant collateral
network that has reopened along the SFA. When the SFAs
occlude at the outflow tract, you can see a portion of the artery
remaining patent through geniculate collaterals. are maintained
with this procedure. In general, when the patients occluded their
arteries, they did not develop limb-threatening ischemia; they
developed the same symptom they had before remote endarterec-
tomy. One patient in the series had an amputation. This was a dia-
betic, renal failure patient who had a patent SFA at the time of
amputation for gangrene of the foot that we could not salvage.
Do you recall that spiral-looking covered stent that I showed
Mark? That was conceived by Tom Fogarty and is an intriguing
concept as the stent will give the artery structural support, yet will
not compromise the collaterals’ vessels. Time will tell if Fogarty is
right once again, but my money is on him.
Dr George Meier (Norfolk, Va). David, I enjoyed that presen-
tation very much. What I want to ask relates to where we are going
with this. I have recently had a couple of conversations with Dr
Moll relative to this topic, and he feels very strongly that relining
the SFA is essential to long-term outcomes. I wondered, based on
your experience, what your current position is relative to relining.
Dr Rosenthal. I think Franz Moll is right; however, you have
two-edged sword. The relining of the endarterectomized SFA
with, for example, a PTFE stent-graft, may compromise your col-
lateral vessels opened at endarterectomy, versus simply “tacking”
plaque at the outflow tract with a stent and leaving the collaterals
patent. The SFA is a different vessel from a high-octane, high-flow
iliac artery, which, after balloon/stent angioplasty, will remain
open. As vascular surgeons, we know better than anybody that the
SFA is a low-flow, low-pressure system that angulates in a postero-
medial plane as it goes toward the popliteal fossa. The SFA is
unique among peripheral arteries, and I believe some form of sup-
ported conduit along the endarterectomized SFA will yield the best
long-term results. Our colleagues in Europe are really the leaders
in this area, and they are already evaluating various conduits.
